- Unilever Indonesia reported a net income of 2.47 trillion rupiah for the first half of 2024.
- This net income represents a 10% decrease year-over-year.
- Earnings per share (EPS) stood at 65 rupiah, down from 72 rupiah compared to the same period last year.
- Net sales for the company amounted to 19.04 trillion rupiah, marking a 6.2% decline from the previous year.
- The company’s stock has 4 buy ratings, 21 hold ratings, and 7 sell ratings from analysts.
A look at Unilever Indonesia Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Unilever Indonesia shows a promising long-term outlook. With a high score in Dividend and Momentum, the company demonstrates solid performance and growth potential. The strong Resilience score indicates its ability to weather economic uncertainties, while the Growth score suggests opportunities for expansion. Although the Value score is moderate, Unilever Indonesia‘s overall outlook appears positive, positioning it well for sustained success in the future.
PT Unilever Indonesia Tbk, known for manufacturing a diverse range of products including soaps, detergents, margarine, and cosmetics among others, seems to have a bright future according to the Smartkarma Smart Scores. The company’s emphasis on dividends and its impressive momentum in the market reflect strength and stability. With a resilient business model and prospects for growth, Unilever Indonesia appears well-equipped to thrive in the long term, making it a company to watch for potential investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
